General Information
Revision date
2015-06-16
Product name
XOPENEX (levalbuterol hydrochloride) Inhalation
Product Synonyms
Levalbuterol; levalbuterol Hydrochloride, (R)-Albuterol
CAS No.
50293-90-8
Icons in SDS
Company Information
company name
Oak Pharmaceuticals, Inc.
e-mail address of the competent person responsible for the Safety Data Sheet
customer.service@akorn.com
GHS Information
Signal word
None
Section 2
Physical hazards
None required.
Health hazards
None required.
Signal word
None required.
Hazard statements
None required.
Precautionary statements
None required.
2.3 Other hazards
None required.
Supplemental label elements
Xopenex® Inhalation Solution contains levalbuterol hydrochloride, the (R)-enantiomer of albuterol, which is a highly potent and relatively selective b2- adrenergic agonist. It is used as a bronchodilator. Frequently reported adverse effects associated with use by inhalation are commonly seen with b2-agonists, and include dizziness, cardiovascular effects (changes in blood pressure or heart rate, and abnormal ECG patterns), metabolic imbalance, and sore nose and throat. There have also been occasional reports of anaphylactic reaction, hives, swelling, rash, and potentially life-threatening paradoxical bronchospasm. 1 of 9
